Novo Nordisk A/S (NVO)
37.82
-1.05
(-2.70%)
USD |
NYSE |
Nov 20, 16:00
37.81
-0.01
(-0.03%)
Pre-Market: 20:00
Novo Nordisk Total Return Level : 67.68 for Nov. 20, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 20, 2026 | 67.68 |
| November 19, 2026 | 69.56 |
| November 18, 2026 | 70.56 |
| November 17, 2026 | 72.83 |
| November 16, 2026 | 74.45 |
| November 13, 2026 | 74.50 |
| November 12, 2026 | 72.75 |
| November 11, 2026 | 73.53 |
| November 10, 2026 | 72.83 |
| November 09, 2026 | 74.05 |
| November 06, 2026 | 72.14 |
| November 05, 2026 | 72.12 |
| November 04, 2026 | 75.48 |
| November 03, 2026 | 71.92 |
| November 02, 2026 | 72.39 |
| October 30, 2026 | 71.58 |
| October 29, 2026 | 70.04 |
| October 28, 2026 | 68.52 |
| October 27, 2026 | 69.20 |
| October 26, 2026 | 70.02 |
| October 23, 2026 | 69.88 |
| October 22, 2026 | 70.56 |
| October 21, 2026 | 69.90 |
| October 20, 2026 | 70.42 |
| October 19, 2026 | 68.75 |
| Date | Value |
|---|---|
| October 16, 2026 | 69.49 |
| October 15, 2026 | 70.19 |
| October 14, 2026 | 68.22 |
| October 13, 2026 | 68.11 |
| October 12, 2026 | 69.04 |
| October 09, 2026 | 69.15 |
| October 08, 2026 | 68.32 |
| October 07, 2026 | 68.47 |
| October 06, 2026 | 67.16 |
| October 05, 2026 | 67.18 |
| October 02, 2026 | 66.79 |
| October 01, 2026 | 66.93 |
| September 30, 2026 | 67.84 |
| September 29, 2026 | 68.56 |
| September 28, 2026 | 69.27 |
| September 25, 2026 | 69.43 |
| September 24, 2026 | 69.11 |
| September 23, 2026 | 68.31 |
| September 22, 2026 | 70.51 |
| September 21, 2026 | 71.22 |
| September 18, 2026 | 77.38 |
| September 17, 2026 | 77.29 |
| September 16, 2026 | 74.64 |
| September 15, 2026 | 76.11 |
| September 14, 2026 | 77.76 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AstraZeneca PLC | 440.08 |
| GSK Plc | 183.76 |
| Johnson & Johnson | 645.40 |
| Eli Lilly & Co. | 3563.61 |
| Merck & Co., Inc. | 413.52 |